Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?

Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?

The current use of combined antiretroviral therapy (cART) is leading to a significant decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 (HIV-1) infection. Nonetheless, none of these therapies can extinguish the virus from the long-lived cellular reservoir, incl...

Full description

Bibliographic Details
Main Authors: Ana Borrajo López, Maria Aránzazu Penedo, Tania Rivera-Baltanas, Daniel Pérez-Rodríguez, David Alonso-Crespo, Carlos Fernández-Pereira, José Manuel Olivares, Roberto Carlos Agís-Balboa
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomedicines
Subjects:
HIV-1 associated neurocognitive disorders
microglia
pharmacological treatment
central nervous system
antiretroviral therapy
Online Access:https://www.mdpi.com/2227-9059/9/8/925

Internet

https://www.mdpi.com/2227-9059/9/8/925

Similar Items